Xencor, Inc. (XNCR) compared with its closest peers (ASRT, GYRE, URGN, KPTI, ZVRA). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Assertio, Gyre Therapeutics, UroGen Pharma, Karyopharm Therapeutics, Zevra Therapeutics, MacroGenics, Heron Therapeutics, Syndax Pharmaceuticals, Phathom Pharmaceuticals and Cryoport share Xencor's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Assertio Holdings, Inc. (ASRT) | $151.83M | -1.9 |
| Gyre Therapeutics, Inc. (GYRE) | $768.30M | 352.0 |
| UroGen Pharma Ltd. (URGN) | $2.28B | -7.3 |
| Karyopharm Therapeutics Inc. (KPTI) | $44.57M | -0.4 |
| Zevra Therapeutics, Inc. (ZVRA) | $701.40M | 6.4 |
| MacroGenics, Inc. (MGNX) | $257.35M | -1.4 |
| Heron Therapeutics, Inc. (HRTX) | $64.55M | -10.8 |
| Syndax Pharmaceuticals, Inc. (SNDX) | $1.74B | -6.4 |
| Phathom Pharmaceuticals, Inc. (PHAT) | $718.00M | -5.5 |
| Cryoport, Inc. (CYRX) | $866.86M | 6.9 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
XNCR overview · XNCR earnings · XNCR financials · XNCR KPIs · XNCR documents · XNCR ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.